Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors

Hepatology

Volumn 27, Issue 1, 1998, Pages 28-34

  Bernardi, M ^a   Galandra, S ^a   Colantoni, A ^a   Trevisani, F ^a   Raimondo, M L ^a   Sica, G ^a   Schepis, F ^a   Mandini, M ^a   Simoni, P ^a   Contin, M ^a   Raimondo, G ^a  

^a Semeiotica Medica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; DISEASE SEVERITY; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERACTIVITY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QT INTERVAL; SUDDEN DEATH; SURVIVAL RATE;

EID: 0031962296     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270106     Document Type: Article

References (40)

1. 1 Kuo CS, Amlie JP, Munakata K, Reddy CP, Surawicz B. Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing and ventricular premature stimulation in canine ventricles. Cardiovasc Res 1983 ; 17: 152–161. MEDLINE
2. 2 Schwartz PJ. Idiopathic long Q‐T syndrome: progress and questions. Am Heart J 1984 ; 109: 399–411.
3. 3 Moss AJ, Robinson J. Clinical features of the idiopathic long QT syndrome. Circulation 1992 ; 85: 140–146.
4. 4 Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. Long Q‐T syndromes: a critical review, new clinical observation and unified hypothesis. Prog Cardiovasc Dis 1988 ; 31: 115–172. MEDLINE
5. 5 Moss AJ. Prolonged long Q‐T syndromes. JAMA 1986 ; 256: 2985–2987. MEDLINE
6. 6 Day PC, James FWO, Butler JT, Campbell RWF. Q‐T prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993 ; 341: 1423–1428. MEDLINE
7. 7 Mohamed R, Forsey PR, Davies MK, Neuberger JM. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end‐stage liver disease. Hepatology 1996 ; 23: 1128–1134. MEDLINE
8. 8 Trevisani F, Sica G, Mainquà P, Caraceni P, Colantoni A, De Notariis S, Mazziotti A, et al. Normalization of prolonged QT interval after liver transplantation in cirrhosis [Abstract]. Hepatology 24 (Suppl): 179A.
9. 9 Surawicz B. Electrolytes and the electrocardiogram. Am J Cardiol 1963 ; 12: 656–662.
10. 10 Oka H, Mochio S, Sato K, Isogai Y. Correlation of altered Q‐T interval and sympathetic nervous system dysfunction in diabetic autonomic neuropathy. Eur Neurol 1994 ; 34: 23–29. MEDLINE
11. 11 Ong JJ, Sarma JSM, Venkataramen K, Levin SR, Singh BN. Circadian rhythmicity of heart rate and QT c interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. Am Heart J 1993 ; 125: 744–752. MEDLINE
12. 12 Satta A, Faedda R, Chiandussi L, Bartoli E. Fluid and electrolytes in liver disease. Gut 1983 ; 59: 64–72.
13. 13 Hendrikse MT, Tuluvath PJ, Triger DR. Natural history of autonomic neuropathy in chronic liver disease. Lancet 1992 ; 339: 1462–1464. MEDLINE
14. 14 Bichet DG, Van Putten VJ, Schrier RW. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982 ; 307: 1552–1557. MEDLINE
15. 15 Henriksen JH, Ring‐Larsen H, Christensen NJ. Sympathetic nervous activity in cirrhosis: a survey of plasma catecholamine studies. J Hepatol 1984 ; 1: 55–65.
16. 16 Bernardi M, Trevisani F, De Palma R, Ligabue A, Capani F, Baraldini M, Gasbarrini G. Chronobiological evaluation of sympathoadrenergic function in cirrhosis. Relationship with arterial pressure and heart rate. Gastroenterology 1987 ; 93: 1178–1186. MEDLINE
17. 17 Green J, Beyar R, Sideman S, Mordechovitz D, Better OS. The “jaundiced heart”: a possible explanation for postoperative shock in obstructive jaundice. Surgery 1986 ; 5: 14–19.
18. 18 Binah O, Bonzom A, Blendis LM, Mordohovich D, Better S. Obstructive jaundice blunts myocardial contractile response to isoprenaline in the dog: a clue to the susceptibility of jaundiced patients to shock? Clin Sci 1985 ; 69: 647–653. MEDLINE
19. 19 Lepeschkin E, Surawicz B. The duration of the Q‐U interval and its components in electrocardiograms of normal persons. Am Heart J 1953 ; 46: 9–20.
20. 20 Johnson PJ. The effect of liver disease on the endocrine system. In: McIntire, N Benhamou, JP Bircher, J Rizzetto, M Rodès, J eds. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press. 1991 ; 1214–1224.
21. 21 Lehmann MH. QT prolongation in end‐stage liver disease: a result of altered sex hormone metabolism? [Letter] Hepatology 1997 ; 26: 244. MEDLINE
22. 22 Pugh RNH, Murray‐Lyon IM, Dawson JL, Pietroni MR, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg 1973 ; 60: 646–649. MEDLINE
23. 23 National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979 ; 28: 1038–1057.
24. 24 Bazett HC. An analysis of the time‐relations of electrocardiogram. Heart 1920 ; 7: 353–370.
25. 25 Goldman MJ. Principles of clinical electrocardiography. 8th ed Los Altos: Lage Medical. 1973: 24.
26. 26 Bernardi M, De Palma R, Trevisani F, Malatesta R, Baraldini M, Cursaro C, Gasbarrini G. Unaltered dopaminergic modulation of aldosterone secretion in cirrhosis. Clin Sci 1988 ; 74: 137–143. MEDLINE
27. 27 Bernardi M, Di Marco C, Trevisani F, De Collibus C, Fornalè L, Baraldini M, Andreone P, et al. The hemodynamic status of preascitic cirrhosis: an evaluation under steady state conditions and after postural change. Hepatology 1992 ; 16: 341–346. MEDLINE
28. 28 Anton AH, Sayre DF. A study of the factors affecting the aluminium oxidetrihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 1962 ; 138: 360–375.
29. 29 Roda A, Festi D, Armanino C, Rizzoli R, Simoni P, Minutello A, Taroni F, et al. Methodological and clinical aspects of bile acid analysis in biological fluids. Prog Clin Biochem 1989 ; 8: 130–137.
30. 30 Smith LH. Diseases of bone and bone mineral metabolism. In: Andreoli, TE Carpenter, CCJ Plum, F Smith, LH eds. Cecil Essentials of Medicine. Philadelphia: Saunders. 1986 ; 502–523.
31. 31 Silvieri R, Veglio M, Chinaglia A, Scaglione P, Cavallo‐Perin P. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. Diab Med 1993 ; 10: 920–924.
32. 32 Kawataki M, Kashima T, Toda H, Tanaka H. Relation between QT interval and heart rate. Applications and limitations of Bazett's formula. J Electrocardiol 1984 ; 17: 371–376. MEDLINE
33. 33 Bernardi M, Rubboli A, Trevisani F, Cancellieri C, Ligabue A, Baraldini M, Gasbarrini G. Reduced cardiovascular responsiveness to exercise‐induced sympathoadrenergic stimulation in patients with cirrhosis. J Hepatol 1991 ; 12: 207–216. MEDLINE
34. 34 Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988 ; 8: 1151–1157. MEDLINE
35. 35 Schwartz PJ, Wolf S. QT interval prolongation as a predictor of sudden death in patients with myocardial infarction. Circulation 1978 ; 57: 1074–1077. MEDLINE
36. 36 Zareba W, Moss AJ, le Cessie S, Locati EH, Robinson JL, Hall WJ, Andrews ML. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol 1995 ; 26: 1685–1691. MEDLINE
37. 37 Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil D. Sex difference in risk of torsade de pointes with DL‐sotalol. Circulation 1996 ; 94: 2535–2541. MEDLINE
38. 38 Schwartz PJ, Periti M, Malliani A. The long Q‐T syndrome. Am Heart J 1975 ; 89: 378–390. MEDLINE
39. 39 Braillon A, Gaudin C, Poo JL, Moreau L, Debaene B, Lebrec D. Plasma catecolamine concentration is a reliable index of sympathetic vascular tone in patients with cirrhosis. Hepatology 1992 ; 15: 58–63. MEDLINE
40. 40 Murakawa Y, Inoue H, Nozaki A, Sugimoto T. Role of sympathovagal interaction in diurnal variation of Q‐T interval. Am J Cardiol 1992 ; 69: 339–343. MEDLINE